Epilepsy Research
Volume 31, Issue 2 , Pages 153-157 , July 1998

Inhibition of [3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: an autoradiographic investigation in human hippocampus

  • G Künig

      Affiliations

    • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany
    • Corresponding Author InformationCorresponding author. Paul-Scherrer-lnstitut, PET-Programm, 5232-Villigen, Switzerland. Tel.: +41 56 3104253; fax: +41 56 3103132; e-mail: kuenig@psi.ch
    • ,
  • B Niedermeyer

      Affiliations

    • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany
    • ,
  • J Deckert

      Affiliations

    • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany
    • ,
  • W Gsell

      Affiliations

    • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany
    • ,
  • G Ransmayr

      Affiliations

    • Department of Neurology, University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria
    • ,
  • P Riederer

      Affiliations

    • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany

Received 15 October 1997 ,Revised 15 March 1998 ,Accepted 27 March 1998.

References 

  1. Bowden CL, Janicak PG, Orsulak P, Swann AC, Davis JM, Calabrese JR, et al. Relation of serum valproate concentration to response in mania. Am. J. Psychiatry. 1996;153:765–770
  2. Clarenbach, P., Fröscher, W., 1992. Antiepileptika, Neuropsychopharmaka. In: P. Riederer, G. Laux, W. Pöldinger (Eds.), Neurpsychopharmaka, Band 6. Springer Verlag, Wien, pp. 57–84.
  3. Farooqui A, Horrocks LA. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 1991;16:171–191
  4. Fredow G, Löscher W. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant model of paroxysmal dystonia. Eur. J. Pharmacol. 1991;192:207–219
  5. Hosford D, Crain B, Cao Z, Bonhaus D, Friedman A, Okazaki M, et al. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA-receptor binding in epileptic human hippocampus. J. Neurosci. 1991;11:428–434
  6. Kelly KM, Gross RA, Macdonald RL. Valproic acid selectively reduces the low-threshold (T) calcium in rat nodose neurons. Neurosci. Lett. 1990;116:233–238
  7. Künig G, Hartmann J, Niedermeyer B, Deckert J, Ransmayr G, Heinsen H, et al. Excitotoxin l-β-oxalyl-amino-alanine (l-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid (AMPA) binding in human hippocampus. Neurosci. Lett. 1994;169:219–222
  8. Larsson OM, Gram L, Schousboe A. Differential effects of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurons and astrocytes. Neuropharmacology. 1986;25:617–625
  9. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 1993;18:485–502
  10. Macdonald RL, Kelly KM. Antiepileptic drug mechanism of action. Epilepsia. 1995;2(Suppl.):2–12
  11. Maitre M, Ciesielski L, Cash C, Mandel P. Comparison of the structural characteristics of the 4-aminobutyrate: 2-oxoglutarate transaminases from rat and human brain, and of their affinities for certain inhibitors. Biochim. Biophys. Acta. 1978;522:385–399
  12. Meldrum, B.S., Garthwaite, J., 1991. Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Lodge, D., Collingridge, G.L. (Eds.), The Pharmacology of Excitatory Amino Acids. A TIPS Special Report, pp. 54–61.
  13. Meldrum BS, Craggs MD, Durmuller N, Smith SE, Chapman AG. The effects of AMPA receptor antagonists on kindled seizures and a reflex epilepsy in rodents and primates. Epilepsy Res. 1992;9(Suppl.):307–311
  14. Pranzatelli M, Nadi NS. Mechanism of action of antiepileptic and antimyoclonic drugs. Adv. Neurol. 1995;67:329–360
  15. Richter A, Löscher W, Löschmann PA. The AMPA receptor antagonist NBQX excerts antidystonic effects in an animal model of idiopathic dystonia. Eur. J. Pharmacol. 1993;231:287–291
  16. Steppuhn KG, Turski L. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J. Pharmacol. Exp. Ther. 1993;265:1063–1070
  17. Turski L, Niemann W, Stephens DN. Differential effects of antiepileptic drugs and β-carbolines on seizures induced by excitatory amino acids. Neuroscience. 1990;39:799–807
  18. Wilder, B.J., Rangel, R.J., 1989. Clinically relevant antiepileptic drug interactions. In: W.H. Pitlick (Ed.), Antiepileptic Drug Interactions. Raven Press, New York, pp. 65–75.
  19. Wilinski SI, Acosta GB, Rubio MC. Valproic acid differs in its in vitro effect on glutamic acid decarboxylase in neonatal and adult rat brain. Gen. Pharmacol. 1996;27:635–638
  20. Young D, Dragunow M. Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus. Neuroreport. 1993;5:81–83

PII: S0920-1211(98)00022-9

Epilepsy Research
Volume 31, Issue 2 , Pages 153-157 , July 1998

Article Tools

* Image Usage & Resolution